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BACKGROUND: The relationship between cigarette smoking and incidence of acoustic neuromas and pituitary tumours is uncertain.
METHODS: We examined the relation between smoking and risk of acoustic neuromas and pituitary tumours in a prospective study of
1.2 million middle-aged women in the United Kingdom.
RESULTS: Over 10.2 million person years of follow-up, 177 women were diagnosed with acoustic neuromas and 174 with pituitary
tumours. Current smokers at recruitment were at significantly reduced risk of incident acoustic neuroma compared with never
smokers (adjusted relative risk (RR)¼0.41, 95% confidence interval (CI)¼0.24–0.70, P¼0.001). Past smokers did not have
significantly different risk of acoustic neuroma than never smokers (RR¼0.87, 95% CI¼0.62–1.22, P¼0.4). Smoking was not
associated with incidence of pituitary tumours (RR in current vs never smokers¼0.91, 95% CI¼0.60–1.40, P¼0.7).
CONCLUSION: Women who smoke are at a significantly reduced risk of acoustic neuromas, but not of pituitary tumours, compared
with never smokers. Acoustic neuromas are much rarer than the cancers that are increased among smokers.
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Acoustic neuromas and pituitary tumours are rare, each
accounting for approximately 10% of all intracranial tumours.
Acoustic neuromas are slow-growing benign tumours arising from
Schwann cells of the eighth cranial nerve (Propp et al, 2006).
Pituitary tumours are typically benign adenomas and may be
hormone secreting or non-functioning (Asa and Ezzat, 2009).
The aetiology of both tumour types is unclear (Evans et al,
2005; McGregor, 2009), with no firmly established common
environmental risk factors. However, recent results from a
multicentre case–control study showed a significantly lower risk
for acoustic neuroma in current smokers than in never smokers
(Schoemaker et al, 2007); no association was found between
smoking and incidence of pituitary tumour (Schoemaker and
Swerdlow, 2009).
We examined the relation between smoking and incident
acoustic neuromas and pituitary tumours in a large prospective
study of middle-aged women in the United Kingdom.
MATERIALS AND METHODS
During 1996–2001, 1.3 million middle-aged women (mean age 56
years) were recruited into the Million Women Study cohort,
completing a recruitment questionnaire about socio-demographic
factors, reproductive and medical history and other personal
characteristics, including details on smoking status. Full details of
the study design and methods are described elsewhere (Million
Women Study Collaborative Group, 1999) and the questionnaire
can be viewed at http://www.millionwomenstudy.org.
All study participants have been flagged on the National Health
Service (NHS) Central Registers and tumour registrations and
deaths are routinely notified to the study investigators. This
information includes the date of each such event and codes the
tumour site and morphology using the 10th revision of the
International Classification of Diseases (ICD-10) (World Health
Organization, 1992). Follow-up is complete for over 99% of the
study population.
Acoustic neuromas were defined as those coded as ICD-10
D33.3, with morphology code ICD-O 9650/0. Pituitary tumours
were defined as those coded as ICD-10 C75.1, D35.2 or D44.3.
Women were classed as current, past or never smokers, as
reported at recruitment. Current smokers were further classified
according to the average number (o15, 15þ) of cigarettes
smoked per day.
Statistical analysis
Women were excluded from the analyses if at recruitment they had
been diagnosed with any type of invasive tumour (other than non-
melanoma skin cancer [C44]) or any non-invasive tumour of the
CNS, or if there was no information on smoking status. Women
were also excluded if they reported having the inherited disorder
neurofibromatosis (Q85.0) at recruitment.
Eligible women contributed person years from the date of
recruitment until the date of registration of an acoustic neuroma
or a pituitary tumour, date of death or end of follow-up, whichever
was the earliest. In addition, women diagnosed with any cancer
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y(except non-melanoma skin cancer) or any non-invasive CNS
tumour during the follow-up period were censored at the date of
diagnosis of that tumour, to avoid potential biases because of the
effect of treatment or of altered surveillance. The end of follow-up
for tumour incidence was 31 December 2007 for East Anglia, South
West and North West (Mersey) regions, 30 June 2007 for Oxford,
Thames, West Midlands and Trent and 31 December 2006 for North
Yorkshire, North West (Manchester/Lancashire) and Scotland.
Relative risks (RRs) and 95% confidence intervals (CIs) were
obtained using Cox proportional hazards models with attained
age as the underlying time variable. The proportional hazards
assumption was assessed using tests based on Schoenfeld
residuals, which showed no evidence of a violation for any of the
exposure comparisons listed in the tables.
Analyses were stratified by region and by age at recruitment,
and as there are no established common environmental risk
factors for either tumour site, we examined the effect of adjusting
for the following potential risk factors separately, and for all
simultaneously: socio-economic status (quintiles based on
Townsend deprivation index; Townsend et al, 1988), height
(o160, 160–164.9, X165cm), body mass index (o25, 25–29.9,
X30kgm
–2), alcohol intake (never, o7, X7 drinks per week),
strenuous exercise (o1, 1, X2 times per week), parity (nullipar-
ous, 1–2 and 3þ full-term pregnancies), age at first birth (o20,
20–24, 25þ years), menopausal status (pre/perimenopausal,
o5 years postmenopause, 5þ years postmenopause) and use of
oral contraceptives (never, o5, X5 years of use) and of hormone
therapy for the menopause (never, past, current). Women with
missing values for any of the adjustment variables were assigned to
a separate category for that variable.
RESULTS
In total, 1240593 women aged 56 years on average at recruitment
were included in the analyses. During 10.2 million person years of
follow-up (an average of 8.2 years per woman), 177 acoustic
neuromas and 174 pituitary tumours were registered. Table 1
shows characteristics of the study population by smoking status. A
total of 607215 (49%) women had ever smoked, and 254992 (21%)
were current smokers.
Women who had ever smoked had a significantly decreased risk
of acoustic neuroma compared with never smokers (adjusted
RR¼0.69, 95% CI¼0.51–0.95, P¼0.02). As shown in Table 2,
risk was significantly lower in current smokers (RR compared with
never smokers¼0.41, 95% CI¼0.24–0.70, P¼0.001) than in past
smokers (RR compared with never smokers¼0.87, 95%
CI¼0.62–1.22, P¼0.4): P for heterogeneity¼0.006. Although
the reduction in risk in current smokers seemed to be greater with
increasing numbers of cigarettes smoked (RRs¼0.53 vs 0.27 in
women who smoked o15 and 15þ cigarettes per day, respec-
tively), this difference was not statistically significant (P for
heterogeneity¼0.2). Smoking was not associated with incidence of
pituitary tumours (RR for ever vs never smokers¼0.99, 95%
CI¼0.73–1.35, P¼0.95; for current vs never smokers, 0.91, 95%
CI¼0.60–1.40, P¼0.7). No material effect on the RRs was seen








Mean age, years (s.d.) 55.3 (4.5) 56.3 (4.9) 56.3 (4.9)
Socio-economic group (% in upper third) 23 33 38
Past use of oral contraceptives (%) 65 64 56
Mean parity (s.d.) 2.3 2.1 2.1
Mean height, cm (s.d.) 161.5 (6.8) 162.3 (6.7) 162.0 (6.7)
Mean body mass index, kgm
–2(s.d.) 25.6 (4.5) 26.7 (4.8) 26.2 (4.6)
Strenuous physical activity Xonce per week (%) 30 41 41
Mean alcohol intake, g per week (s.d.) 47.1 (59.6) 53.8 (58.7) 37.1 (45.8)
Current use of hormone replacement therapy (%) 36 36 31
Follow-up for incident acoustic neuromas and pituitary tumours
Person-years of follow-up (millions) 2.05 2.88 5.23
Number of incident acoustic neuroma cases 16 52 109
Number of incident pituitary tumour cases 31 52 91
Table 2 Relative risks (RRs) and 95% confidence intervals (CIs) for incident acoustic neuroma and pituitary tumour in relation to smoking status in the
Million Women Study cohort
Acoustic neuroma Pituitary tumours
Smoking status n cases RR
a (95%CI) RR
b (95% CI) n cases RR
a (95%CI) RR
b (95% CI)
Never smoker 109 1.00 1.00 91 1.00 1.00
Past smoker 52 0.87 (0.62–1.21) 0.87 (0.62–1.22) 52 1.04 (0.74–1.47) 1.04 (0.74–1.47)
Current smoker 16 0.38 (0.22–0.64) 0.41 (0.24–0.70) 31 0.88 (0.59–1.33) 0.91 (0.60–1.40)
Current o15 cigarettes/day 11 0.50 (0.27–0.93) 0.53 (0.28–1.00) 21 1.14 (0.71–1.84) 1.19 (0.73–1.94)
Current 15+ cigarettes/day 5 0.25 (0.10–0.61) 0.27 (0.11–0.66) 10 0.60 (0.31–1.15) 0.60 (0.31–1.18)
aRRs stratified by region and by age at recruitment, with attained age as the underlying time variable.
bRRs stratified by region and by age at recruitment, and adjusted for socio-
economic status, alcohol intake, height, body mass index, strenuous exercise, parity, age at first birth, menopausal status and use of oral contraceptives or hormone therapy for
the menopause, with attained age as the underlying time variable.
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ywith either individual or simultaneous (Table 2) adjustment for the
10 potential confounding factors considered.
DISCUSSION
In this large prospective study, incidence of acoustic neuroma was
significantly and substantially decreased in current smokers.
Incidence of pituitary tumours was not significantly associated
with smoking. Our findings are consistent with the results from the
only relevant earlier epidemiological study, a case–control study
including 563 acoustic neuromas (RR for current vs never
smokers¼0.5; Schoemaker et al, 2007) and 299 pituitary tumours
(RR for ever vs never smokers¼1.2; Schoemaker and Swerdlow,
2009).
Strengths of this investigation include the prospective study
design, large study size and complete and non-differential follow-
up for cancer incidence. Despite the large sample size, the numbers
of cases were still relatively small and the study had limited power
to investigate smoking by amount or duration.
No clear association has been found between smoking and
incidence of other tumours of the CNS, including glioma or
meningioma, either in this cohort (Benson et al, 2008) or in other
studies (Mandelzweig et al, 2009). Possible mechanisms for an
association between smoking and risk of acoustic neuroma
include, as well as direct effects of tobacco carcinogens, the effects
of cigarette smoking on hormonal status (Kapoor and Jones, 2005);
female sex hormones may have a function in development of some
central nervous system tumours, including acoustic neuroma
(Benson et al, 2010). A reduced risk of acoustic neuromas among
smokers, if confirmed, would have minimal implications for public
health: acoustic neuromas are much rarer than the cancers that are
increased among smokers.
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Million Women Study Steering Committee
Joan Austoker*, Emily Banks, Valerie Beral, Judith Church, Ruth
English, Jane Green, Julietta Patnick, Richard Peto, Gillian Reeves,
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*Deceased.
Million Women Study Coordinating Centre Staff
Simon Abbott, Miranda Armstrong, Krys Baker, Angela Balkwill,
Vicky Benson, Valerie Beral, Judith Black, Anna Brown, Diana Bull,
Benjamin Cairns, James Chivenga, Barbara Crossley, Dave Ewart,
Sarah Ewart, Lee Fletcher, Laura Gerrard, Adrian Goodill, Isobel
Green, Jane Green, Elizabeth Hilton, Joy Hooley, Sau Wan Kan,
Carol Keene, Oksana Kirichek, Nicky Langston, Bette Liu, Maria-
Jose Luque, Maria MacGregor, Lynn Pank, Kirstin Pirie, Gillian
Reeves, Emma Sherman, Evie Sherry-Starmer, Moya Simmonds,
Elizabeth Spencer, Helena Strange, Sia ˆn Sweetland, Alison Timad-
jer, Sarah Tipper, Ruth Travis, Xiaosi Wang, Joanna Watson,
Stephen Williams, Lucy Wright, Tienyu Yang, Heather Young.
Collaborating UK NHS Breast Screening Centres
Avon, Aylesbury, Barnsley, Basingstoke, Bedfordshire and Hert-
fordshire, Cambridge and Huntingdon, Chelmsford and Colche-
ster, Chester, Cornwall, Crewe, Cumbria, Doncaster, Dorset, East
Berkshire, East Cheshire, East Devon, East of Scotland, East
Suffolk, East Sussex, Gateshead, Gloucestershire, Great Yarmouth,
Hereford and Worcester, Kent, Kings Lynn, Leicestershire, Liver-
pool, Manchester, Milton Keynes, Newcastle, North Birmingham,
North East Scotland, North Lancashire, North Middlesex, North
Nottingham, North of Scotland, North Tees, North Yorkshire,
Nottingham, Oxford, Portsmouth, Rotherham, Sheffield, Shrop-
shire, Somerset, South Birmingham, South East Scotland, South
East Staffordshire, South Derbyshire, South Essex, South Lanca-
shire, South West Scotland, Surrey, Warrington Halton St Helens
and Knowsley, Warwickshire Solihull and Coventry, West Berk-
shire, West Devon, West London, West Suffolk, West Sussex,
Wiltshire, Winchester, Wirral, Wycombe.
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